Company & Sponsor Intelligence
Fudan University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting0
Completed2
Countries1
Therapeutic footprint
depressionepilepsyparkinsonsstroke
Indexed studies
NCT03378687A Clinical Study of Children With Status Epilepticus in China
epilepsy · ChinaUNKNOWN
epilepsy · ChinaUNKNOWN
NCT00656253Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease
parkinsons · ChinaPHASE2, PHASE3
parkinsons · ChinaPHASE2, PHASE3
NCT00710164Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke
stroke · ChinaPHASE2, PHASE3
stroke · ChinaPHASE2, PHASE3
NCT01200719Transcranial Alternating Current Stimulation
stroke · ChinaPHASE4
stroke · ChinaPHASE4
NCT04984070Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety
depression · ChinaNA
depression · ChinaNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →